Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osmotic Agents Will Improve the Midline Shift in Middle Cerebral Artery Stroke Larger Than 70 cc by 1 mm

NCT04156490 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04156490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04156490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osmotic Agents Will Improve the Midline Shift in Middle Cerebral Artery Stroke Larger Than 70 cc by 1 mm
Lead sponsor
University of Minnesota
Phase
Observational
Overall status
Completed
Start date
February 10, 2018
Completion date
June 30, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, mca infarction